LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 39

Search options

  1. Article ; Online: Changing the outcome of osteoarthritis: still a challenge for cyclooxygenase 2 inhibitors.

    Lories, Rik J U

    Arthritis and rheumatism

    2012  Volume 64, Issue 1, Page(s) 37–39

    MeSH term(s) Animals ; Arthritis, Experimental/enzymology ; Celecoxib ; Cyclooxygenase 2 Inhibitors/pharmacology ; Female ; Humans ; Male ; Osteoarthritis/enzymology ; Osteoarthritis, Knee/enzymology ; Pyrazoles/pharmacology ; Sulfonamides/pharmacology
    Chemical Substances Cyclooxygenase 2 Inhibitors ; Pyrazoles ; Sulfonamides ; Celecoxib (JCX84Q7J1L)
    Language English
    Publishing date 2012-01
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 127294-9
    ISSN 1529-0131 ; 0004-3591 ; 2326-5191
    ISSN (online) 1529-0131
    ISSN 0004-3591 ; 2326-5191
    DOI 10.1002/art.33330
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inflammation and ankylosis: still an enigmatic relationship in spondyloarthritis.

    Lories, Rik J U / Dougados, Maxime

    Annals of the rheumatic diseases

    2012  Volume 71, Issue 3, Page(s) 317–318

    MeSH term(s) Female ; Humans ; Male ; Ossification, Heterotopic/etiology ; Spine/pathology ; Spondylitis, Ankylosing/complications
    Language English
    Publishing date 2012-03
    Publishing country England
    Document type Comment ; Editorial
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2011-200842
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pathophysiology of new bone formation and ankylosis in spondyloarthritis.

    Lories, Rik J U / Schett, Georg

    Rheumatic diseases clinics of North America

    2012  Volume 38, Issue 3, Page(s) 555–567

    Abstract: The outcome of patients suffering from spondyloarthritis is determined by chronic inflammation and new bone formation leading to ankylosis. The latter process manifests by new cartilage and bone formation leading to joint or spine fusion. This article ... ...

    Abstract The outcome of patients suffering from spondyloarthritis is determined by chronic inflammation and new bone formation leading to ankylosis. The latter process manifests by new cartilage and bone formation leading to joint or spine fusion. This article discusses the main mechanisms of new bone formation in spondyloarthritis. It reviews the key molecules and concepts of new bone formation and ankylosis in animal models of disease and translates these findings to human disease. In addition, proposed biomarkers of new bone formation are evaluated and the translational current and future challenges are discussed with regards to new bone formation in spondyloarthritis.
    MeSH term(s) Ankylosis/metabolism ; Ankylosis/pathology ; Ankylosis/physiopathology ; Biomarkers/metabolism ; Chronic Disease ; Humans ; Inflammation/metabolism ; Osteogenesis/physiology ; Spine/pathology ; Spondylarthritis/metabolism ; Spondylarthritis/pathology ; Spondylarthritis/physiopathology ; Spondylitis, Ankylosing/metabolism ; Spondylitis, Ankylosing/pathology ; Spondylitis, Ankylosing/physiopathology
    Chemical Substances Biomarkers
    Language English
    Publishing date 2012-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 92118-x
    ISSN 1558-3163 ; 0889-857X
    ISSN (online) 1558-3163
    ISSN 0889-857X
    DOI 10.1016/j.rdc.2012.08.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Targets, models and challenges in osteoarthritis research.

    Thysen, Sarah / Luyten, Frank P / Lories, Rik J U

    Disease models & mechanisms

    2015  Volume 8, Issue 1, Page(s) 17–30

    Abstract: Osteoarthritis is a chronic degenerative disorder of the joint and represents one of the most common diseases worldwide. Its prevalence and severity are increasing owing to aging of the population, but treatment options remain largely limited to ... ...

    Abstract Osteoarthritis is a chronic degenerative disorder of the joint and represents one of the most common diseases worldwide. Its prevalence and severity are increasing owing to aging of the population, but treatment options remain largely limited to painkillers and anti-inflammatory drugs, which only provide symptomatic relief. In the late stages of the disease, surgical interventions are often necessary to partially restore joint function. Although the focus of osteoarthritis research has been originally on the articular cartilage, novel findings are now pointing to osteoarthritis as a disease of the whole joint, in which failure of different joint components can occur. In this Review, we summarize recent progress in the field, including data from novel 'omics' technologies and from a number of preclinical and clinical trials. We describe different in vitro and in vivo systems that can be used to study molecules, pathways and cells that are involved in osteoarthritis. We illustrate that a comprehensive and multisystem approach is necessary to understand the complexity and heterogeneity of the disease and to better guide the development of novel therapeutic strategies for osteoarthritis.
    MeSH term(s) Animals ; Biomarkers/metabolism ; Bone and Bones/pathology ; Cartilage, Articular/pathology ; Clinical Trials as Topic ; Disease Models, Animal ; Epigenomics ; Genomics ; Humans ; Inflammation ; Joints/pathology ; Mice ; Osteoarthritis/pathology ; Osteoarthritis/physiopathology ; Proteomics ; Transcriptome
    Chemical Substances Biomarkers
    Language English
    Publishing date 2015-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ISSN 1754-8411
    ISSN (online) 1754-8411
    DOI 10.1242/dmm.016881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Joint homeostasis, restoration, and remodeling in osteoarthritis.

    Lories, Rik J U

    Best practice & research. Clinical rheumatology

    2008  Volume 22, Issue 2, Page(s) 209–220

    Abstract: Osteoarthritis is the major cause of joint failure. The outcome of the disease process is determined by complex interactions between cells and molecules steering homeostasis, destruction, restoration, and remodeling. The articular cartilage has a limited ...

    Abstract Osteoarthritis is the major cause of joint failure. The outcome of the disease process is determined by complex interactions between cells and molecules steering homeostasis, destruction, restoration, and remodeling. The articular cartilage has a limited restoration and repair capacity. Genetic studies in humans and the development of mouse models have identified the role of signaling pathways that are important for skeletal development in the postnatal biology and pathology of articular cartilage. These include bone morphogenetic protein, transforming growth factor beta, fibroblast growth factor, wingless-type signaling, and their respective antagonists such as noggin and frizzled related protein. The synovium is prone to inflammation and emerging evidence suggests that innate and adaptive immune responses are important. Bone and cartilage form a biomechanical unit; stiffer bones might impair cartilage homeostasis. The biology of frizzled related protein provides a basis for the hypothesized inverse relationship between osteoarthritis and osteoporosis.
    MeSH term(s) Bone Remodeling/physiology ; Cartilage, Articular/physiopathology ; Homeostasis/physiology ; Humans ; Joints/physiopathology ; Osteoarthritis/physiopathology ; Signal Transduction/physiology ; Synovial Membrane/physiopathology
    Language English
    Publishing date 2008-04
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2052323-3
    ISSN 1521-6942
    ISSN 1521-6942
    DOI 10.1016/j.berh.2007.12.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Animal models of spondyloarthritis.

    Lories, Rik J U

    Current opinion in rheumatology

    2006  Volume 18, Issue 4, Page(s) 342–346

    Abstract: Purpose of review: The aim of this article is to review new insights into spondyloarthritis obtained in animal models during the last year.: Recent findings: HLA-B27 misfolding has been demonstrated in HLA-B27/human beta2-microglobulin transgenic ... ...

    Abstract Purpose of review: The aim of this article is to review new insights into spondyloarthritis obtained in animal models during the last year.
    Recent findings: HLA-B27 misfolding has been demonstrated in HLA-B27/human beta2-microglobulin transgenic rats. HLA-B27 misfolding is associated with a typical unfolded protein stress response and with an interferon-response signature. Prebiotic treatment of these rats reduced colitis and arthritis. Proteoglycan-induced spondylitis is distinct from proteoglycan-induced arthritis. Specific susceptibility loci for proteoglycan-induced spondylitis have been demonstrated. Bone morphogenetic proteins are important in new cartilage and bone formation in ankylosing enthesitis. Psoriasis and psoriatic arthritis-like disease develops in conditional double JunB/c-Jun knockout mice.
    Summary: Insights into the molecular signaling pathways driving HLA-B27 associated spondylitis, autoimmune spondylitis, ankylosing enthesitis and psoriasis, resulting from animal models, identify new and specific therapeutic targets in spondyloarthritis.
    MeSH term(s) Animals ; Disease Models, Animal ; Genes, jun ; HLA-B Antigens/immunology ; Humans ; Mice ; Mice, Knockout ; Psoriasis/genetics ; Spondylitis, Ankylosing/genetics ; Spondylitis, Ankylosing/immunology
    Chemical Substances HLA-B Antigens
    Language English
    Publishing date 2006-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/01.bor.0000231900.81677.c5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Targets, models and challenges in osteoarthritis research

    Sarah Thysen / Frank P. Luyten / Rik J. U. Lories

    Disease Models & Mechanisms, Vol 8, Iss 1, Pp 17-

    2015  Volume 30

    Abstract: Osteoarthritis is a chronic degenerative disorder of the joint and represents one of the most common diseases worldwide. Its prevalence and severity are increasing owing to aging of the population, but treatment options remain largely limited to ... ...

    Abstract Osteoarthritis is a chronic degenerative disorder of the joint and represents one of the most common diseases worldwide. Its prevalence and severity are increasing owing to aging of the population, but treatment options remain largely limited to painkillers and anti-inflammatory drugs, which only provide symptomatic relief. In the late stages of the disease, surgical interventions are often necessary to partially restore joint function. Although the focus of osteoarthritis research has been originally on the articular cartilage, novel findings are now pointing to osteoarthritis as a disease of the whole joint, in which failure of different joint components can occur. In this Review, we summarize recent progress in the field, including data from novel ‘omics’ technologies and from a number of preclinical and clinical trials. We describe different in vitro and in vivo systems that can be used to study molecules, pathways and cells that are involved in osteoarthritis. We illustrate that a comprehensive and multisystem approach is necessary to understand the complexity and heterogeneity of the disease and to better guide the development of novel therapeutic strategies for osteoarthritis.
    Keywords Osteoarthritis ; Cartilage ; Bone ; Animal models ; Medicine ; R ; Pathology ; RB1-214
    Language English
    Publishing date 2015-01-01T00:00:00Z
    Publisher The Company of Biologists
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: WNT Signaling in osteoarthritis and osteoporosis: what is the biological significance for the clinician?

    Lodewyckx, Liesbet / Lories, Rik J U

    Current rheumatology reports

    2009  Volume 11, Issue 1, Page(s) 23–30

    Abstract: Osteoporosis and osteoarthritis are common musculoskeletal disorders in which cause and outcome are determined by genetic and environmental factors. The WNT signaling pathway plays an important role in skeletal development and growth. Polymorphisms in a ... ...

    Abstract Osteoporosis and osteoarthritis are common musculoskeletal disorders in which cause and outcome are determined by genetic and environmental factors. The WNT signaling pathway plays an important role in skeletal development and growth. Polymorphisms in a number of genes that belong to this pathway are associated with osteoarthritis and/or osteoporosis. This suggests a role for this molecular signaling pathway in postnatal joint and bone homeostasis and pathology. Increased activity of WNT signaling strengthens the bone but may have adverse effects on the articular cartilage. Frizzled related protein (FRZB) plays a role in both bone and cartilage. Better understanding of the WNT pathway and its modulators may lead to specific therapeutics for both osteoarthritis and osteoporosis. This review focuses on recent studies in human genetics and animal models and highlights the potential clinical relevance of this rapidly evolving field of research.
    MeSH term(s) Animals ; Disease Models, Animal ; Glycoproteins/genetics ; Glycoproteins/metabolism ; Humans ; Intracellular Signaling Peptides and Proteins ; Osteoarthritis/genetics ; Osteoarthritis/metabolism ; Osteoporosis/genetics ; Osteoporosis/metabolism ; Signal Transduction ; Wnt Proteins/genetics ; Wnt Proteins/metabolism
    Chemical Substances Glycoproteins ; Intracellular Signaling Peptides and Proteins ; WD repeat containing planar cell polarity effector ; Wnt Proteins
    Language English
    Publishing date 2009-01-24
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057357-1
    ISSN 1534-6307 ; 1523-3774
    ISSN (online) 1534-6307
    ISSN 1523-3774
    DOI 10.1007/s11926-009-0004-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Osteoarthritis, a disease bridging development and regeneration.

    Lories, Rik J U / Luyten, Frank P

    BoneKEy reports

    2012  Volume 1, Page(s) 136

    Abstract: The osteoarthritic diseases are common disorders characterized by progressive destruction of the articular cartilage in the joints, and associated with remodeling of the subchondral bone, synovitis and the formation of bone outgrowths at the joint ... ...

    Abstract The osteoarthritic diseases are common disorders characterized by progressive destruction of the articular cartilage in the joints, and associated with remodeling of the subchondral bone, synovitis and the formation of bone outgrowths at the joint margins, osteophytes. From the clinical perspective, osteoarthritis leads to joint pain and loss of function. Osteoarthritis is the leading cause of progressive disability. New data from genetic, translational and basic research have demonstrated that pathways with essential roles in joint and bone development also contribute to the postnatal homeostasis of the articular cartilage and are involved in osteoarthritis, making these potential therapeutic targets. Other systems of interest are the tissue-destructive enzymes that break down the extracellular matrix of the cartilage as well as mediators of inflammation that contribute to synovitis. However, the perspective of a durable treatment over years to decades highlights the need for a personalized medicine approach encompassing a global view on the disease and its management, thereby including nonpharmaceutical approaches such as physiotherapy and advanced surgical methods. Integration of novel strategies based on their efficacy and safety with the identification of individuals at risk and optimal individual rehabilitation management remains a major challenge for the medical community in particular, as the incidence of osteoarthritis is likely to further increase with the overall aging of the population.
    Language English
    Publishing date 2012-08-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2816308-4
    ISSN 2047-6396
    ISSN 2047-6396
    DOI 10.1038/bonekey.2012.136
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo.

    Braem, Kirsten / Luyten, Frank P / Lories, Rik J U

    Annals of the rheumatic diseases

    2012  Volume 71, Issue 5, Page(s) 722–728

    Abstract: Objectives: To investigate p38 mitogen activated protein kinase (MAPK) signalling in an in vitro model of bone morphogenetic protein (BMP) and transforming growth factor β (TGFβ)-induced chondrogenesis and in vivo, with specific attention to its ... ...

    Abstract Objectives: To investigate p38 mitogen activated protein kinase (MAPK) signalling in an in vitro model of bone morphogenetic protein (BMP) and transforming growth factor β (TGFβ)-induced chondrogenesis and in vivo, with specific attention to its potential role in ankylosing enthesitis.
    Methods: Human periosteum-derived cells (hPDCs) were cultured in pellets and stimulated with BMP2 or TGFβ1 in the presence or absence of a p38 inhibitor SB203580 or proinflammatory cytokines. Chondrogenic differentiation was evaluated using quantitative PCR. Male DBA/1 mice from different litters were caged together at the age of 8 weeks and treated with SB203580 in both a preventive and therapeutic strategy. The mice were evaluated for prospective signs of arthritis and the toe joints were analysed histologically to assess disease severity.
    Results: p38 inhibition by SB203580 and proinflammatory cytokines downregulated chondrogenic markers in pellet cultures stimulated by BMP2 or TGFβ1. In contrast, the in vivo experiments resulted in an increased clinical incidence of arthritis and pathology severity score, reflecting progression towards ankylosis in mice given SB203580.
    Conclusion: Inhibition of p38 inhibited chondrogenic differentiation of progenitor cells, showing that not only the SMAD signalling pathways and also alternative activation of MAPKs including p38 contribute to chondrogenesis. Such an inhibitory effect is not found in an in vivo model of joint ankylosis and spondyloarthritis. Increased incidence and severity of disease in preventive experiments and shifts in disease stages in a therapeutic experimental set-up suggest that specific inhibition of p38 may have deleterious rather than beneficial effects.
    MeSH term(s) Animals ; Ankylosis/drug therapy ; Ankylosis/genetics ; Ankylosis/physiopathology ; Bone Morphogenetic Proteins/pharmacology ; Cell Proliferation/drug effects ; Cells, Cultured ; Chondrocytes/drug effects ; Chondrocytes/pathology ; Chondrogenesis/drug effects ; Chondrogenesis/genetics ; Disease Models, Animal ; Enzyme Activation/drug effects ; Enzyme Inhibitors/pharmacology ; Gene Expression/drug effects ; Imidazoles/pharmacology ; Male ; Mice ; Mice, Inbred DBA ; Periosteum/cytology ; Periosteum/drug effects ; Pyridines/pharmacology ; Signal Transduction/drug effects ; Smad Proteins/genetics ; Smad Proteins/metabolism ; Spondylitis, Ankylosing/drug therapy ; Spondylitis, Ankylosing/metabolism ; Spondylitis, Ankylosing/pathology ; Transforming Growth Factor beta/pharmacology ; p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors ; p38 Mitogen-Activated Protein Kinases/biosynthesis ; p38 Mitogen-Activated Protein Kinases/genetics
    Chemical Substances Bone Morphogenetic Proteins ; Enzyme Inhibitors ; Imidazoles ; Pyridines ; Smad Proteins ; Transforming Growth Factor beta ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; SB 203580 (OU13V1EYWQ)
    Language English
    Publishing date 2012-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2011-200377
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top